Hepatocyte growth factor and HER2/neu downregulate expression of apoptosis-inducing factor in non-small cell lung cancer.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Oncology Report

• Publication date

  2014-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/or.2013.2867PMID 24276579
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ATR and Chk1 Suppress a Caspase-3–Dependent Apoptotic Response Following DNA Replication Stress

  2009cited by this paper
• Hepatocyte growth factor induces hypoxia‐related interleukin‐8 expression in lung adenocarcinoma cells

  2009cited by this paper
• Expression of short‐form oncostatin M receptor as a decoy receptor in lung adenocarcinomas

  2008cited by this paper
• HGF increases cisplatin resistance via down-regulation of AIF in lung cancer cells.

  2008cited by this paper
• Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation.

  2008cited by this paper
• Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations.

  2008cited by this paper
• Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.

  2007cited by this paper
• Reversal of inflammation‐associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by wogonin and chrysin

  2007cited by this paper
• Integrin-regulated FAK-Src signaling in normal and cancer cells.

  2006cited by this paper
• Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation

  2006cited by this paper
• Cigarette smoking induces overexpression of hepatocyte growth factor in type II pneumocytes and lung cancer cells.

  2006cited by this paper
• Her2-Targeted Therapies in Non–Small Cell Lung Cancer

  2006cited by this paper
• NNK-induced hamster lung adenocarcinomas over-express beta2-adrenergic and EGFR signaling pathways.

  2005cited by this paper
• Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.

  2005cited by this paper
• Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells.

  2005cited by this paper
• Expression spectra of matrix metalloproteinases in metastatic non-small cell lung cancer.

  2004cited by this paper
• Inhibition of Chk1 by Activated PKB/Akt

  2004cited by this paper
• Cell-cycle checkpoints and cancer

  2004cited by this paper
• Tobacco Carcinogen-Induced Cellular Transformation Increases Activation of the Phosphatidylinositol 3′-Kinase/Akt Pathway in Vitro and in Vivo

  2004cited by this paper
• Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival.

  2003cited by this paper
• pp60c-src activation in lung adenocarcinoma.

  2003cited by this paper
• Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells.

  2003cited by this paper
• ATM and related protein kinases: safeguarding genome integrity

  2003cited by this paper
• Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer.

  2003cited by this paper
• Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.

  2002cited by this paper
• Smoking-related DNA and protein adducts in human tissues.

  2002cited by this paper
• Increased Expression of Dihydrodiol Dehydrogenase Induces Resistance to Cisplatin in Human Ovarian Carcinoma Cells*

  2002cited by this paper
• Nicotinic receptor-mediated activation by the tobacco-specific nitrosamine NNK of a Raf-1/MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells

  2001cited by this paper
• Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer.

  2001cited by this paper
• Revisions in the International System for Staging Lung Cancer.

  1997cited by this paper
• Risk factors for primary lung cancer among non-smoking women in Taiwan.

  1997cited by this paper
• Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines.

  1996cited by this paper
• β-Adrenergic Mitogenic Signal Transduction in Peripheral Lung Adenocarcinoma: Implications for Individuals with Preexisting Chronic Lung Disease

  1995cited by this paper
• Beta-adrenergic mitogenic signal transduction in peripheral lung adenocarcinoma: implications for individuals with preexisting chronic lung disease.

  1995cited by this paper
• Functional characterization of a nonclassical nicotine receptor associated with inositolphospholipid breakdown and mobilization of intracellular calcium pools.

  1994cited by this paper
• Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS).

  1993cited by this paper
• Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer.

  1993cited by this paper
• Nicotine: a precursor for carcinogens.

  1985cited by this paper
• Smoking abstinence and small cell lung cancer survival. An association.

  1980cited by this paper
• Evaluation of survival data and two new rank order statistics arising in its consideration.

  1966cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Targeted Therapies Modulating Mesenchymal–Epithelial Transition-Linked Oncogenic Signaling in the Tumor Microenvironment: Comparative Profiling of Capmatinib, Bemcentinib, and Galunisertib

  2025cites this paper
• Prognostic Value of Apoptosis-Inducing Factor (AIF) in Germ Cell Tumors

  2021cites this paper
• Estrogen receptor β promotes the vasculogenic mimicry (VM) and cell invasion via altering the lncRNA-MALAT1/miR-145-5p/NEDD9 signals in lung cancer

  2018cites this paper
• Focal adhesion kinase (FAK) is associated with poor prognosis in urinary bladder carcinoma.

  2018cites this paper
• Complex Structured Fluorescent Polythiophene Graft Copolymer as a Versatile Tool for Imaging, Targeted Delivery of Paclitaxel, and Radiotherapy.

  2016cites this paper
• Downregulation of AIF by HIF-1 contributes to hypoxia-induced epithelial-mesenchymal transition of colon cancer.

  2016cites this paper
• MicroRNA-22E Inhibits HER-3 Protein Expression to Facilitate Metastasis of Lung Adenocarcinomas

  2015cites this paper
• Regulation of metastatic ability and drug resistance in pulmonary adenocarcinoma by matrix rigidity via activating c-Met and EGFR.

  2015cites this paper
• AIF inhibits tumor metastasis by protecting PTEN from oxidation

  2015cites this paper
• Recent Progress and Advances in HGF/MET-Targeted Therapeutic Agents for Cancer Treatment

  2015cites this paper
• The interrelationship between HER2 and CASP3/8 with apoptosis in different cancer cell lines

  2014cites this paper
• Comparison of Intracellular Stress Response of NCI-H526 Small Cell Lung Cancer (SCLC) Cells to Platinum(II) Cisplatin and Platinum(IV) Oxoplatin

  2014influential citation
• Deciphering the role of ErbB2/HER2 in cancer cell lines: a proto-oncogene with antiapoptotic activity

  2014cites this paper